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ABSTRACT
Aims The management of asymptomatic patients with
mitral regurgitation (MR) remains controversial. Exercise-
induced pulmonary hypertension (ExPHT) was recently
reported as a strong predictor of rapid onset of
symptoms. We hypothesised that ExPHT is a predictor of
postoperative cardiovascular events in patients with
primary MR.
Methods and results One hundred and two patients
with primary MR, no or mild symptoms (New York heart
association (NYHA) ≤2), and no LV dysfunction/
dilatation, were prospectively recruited in 3 centres and
underwent exercise-stress echocardiography. The
presence of ExPHT was deﬁned as an exercise systolic
pulmonary arterial pressure >60 mm Hg. All patients
were closely followed up and operated on when
indication for surgery was reached. Postoperative events
were deﬁned as the occurrence of atrial ﬁbrillation (AF),
stroke, cardiac-related hospitalisation or death. Among
the 102 patients included, 59 developed ExPHT (58%).
These patients were signiﬁcantly older than those
without ExPHT (p=0.01). During a mean postoperative
follow-up of 50±23 months, 28 patients (26%)
experienced a predeﬁned cardiovascular event. Patients
with ExPHT had signiﬁcantly higher rate of postoperative
events (39% vs 12%, p=0.005); the rate of events was
still higher in these patients (32% vs 9%, p=0.013),
even when excluding early postoperative AF (ie, within
48 h). Event-free survival was signiﬁcantly lower in the
ExPHT group (all events: 5-year: 60±8% vs 88±5%,
p=0.007, events without early AF: 5-year: 67±7% vs
90±4%, p=0.02). Using Cox multivariable analysis,
ExPHT remained independently associated with higher
risk of postoperative events in all models (all p≤0.04).
Conclusions ExPHT is associated with increased risk of
adverse cardiac events following mitral valve surgery in
patients with primary MR.
INTRODUCTION
The management of asymptomatic patients with
primary mitral regurgitation (MR) and no LV dys-
function or dilatation remains controversial.1 2 In
these patients, mitral valve surgery is recommended
(class IIa indication, level of evidence C) in
European Society of Cardiology (ESC) and
American College of Cardiology and American
Heart Association (ACC/AHA) guidelines in the
presence of resting pulmonary hypertension (PHT)
as deﬁned as a systolic pulmonary arterial pressure
(SPAP) >50 mm Hg.3 4 However, in the absence
of symptoms, resting PHT is infrequent.5–10 In
contrast, exercise PHT is more common in
asymptomatic primary MR9–11 and was shown to
be superior to resting PHT to predict the occur-
rence of symptoms and the need for surgery
during follow-up.9 10 Although exercise PHT is a
potential or indication (ESC class IIbC) for mitral
valve repair in the current guidelines (level of evi-
dence C), there is no data in the literature regard-
ing the postoperative outcome of patients with
exercise PHT. Our group has shown that exercise
PHT is independently determined by older age,
resting SPAP and exercise MR severity, which are,
in turn, all powerful predictors of poorer
outcomes.7 8 12–14
Therefore, we hypothesised that exercise PHT is
a predictor of postoperative cardiovascular events




From July 2007 to August 2012, we prospectively
included 102 consecutive patients with degenera-
tive MR who underwent mitral valve surgery in
one of the following centres: CHU Sart Tilman,
Liège, Belgium (n=36, 35%), Centre Hospitalier
Universitaire de Rennes, France (n=49, 48%) and
Quebec Heart and Lung Institute, Quebec, Canada
(n=17, 17%). The inclusion criteria were: (1)
moderate or severe degenerative MR (deﬁned as
an effective regurgitant oriﬁce (ERO) area
≥20 mm² and/or a regurgitant volume (RV)
≥30 mL); (2) asymptomatic or mildly symptomatic
patients (New York heart association (NYHA)
functional class ≤II); (3) Preserved LVEF (>60%)
and normal LV end-systolic diameter (<45 mm);
(4) mitral valve surgery during follow-up with
class I or class IIa indication. All patients had
resting and exercise Doppler-echocardiography at
the time of inclusion in the study. Patients who
underwent mitral valve surgery during follow-up
with class IIb indication were excluded. The data
from the three centres were merged in a compu-
terised database and analysed in Liège, Belgium.
All patients were in sinus rhythm and none had
concomitant >mild valvular stenosis or regurgita-
tion. Patients with suspected coronary artery
disease, with ST segment changes during exercise
or exercise-induced wall motion abnormalities
were excluded. The relevant institutional review
boards approved the present protocol and all
patients gave written informed consent.
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Demographic and clinical data
Demographic and clinical data included age, gender, height,
weight, history of smoking, documented diagnosis of systemic
hypertension, hypercholesterolaemia, overweight and diabetes.
Exercise echocardiography
Following comprehensive resting Doppler echocardiogram, all
patients performed a symptom-limited graded bicycle exercise
test in a semisupine position on a dedicated tilting exercise table
(Ecogito, Easystress and Ergoline, 800 ER, Cosmed). The initial
workload of 25W was maintained for 2 min; the workload was
increased every 2 min by 25 W. Blood pressure and a 12-lead
ECG were recorded every 2 min.
Echocardiographic measurements
Echocardiographic examinations were performed with a Vivid 7
or Vivid 9 imaging device (GE Healthcare, Little Chalfont, UK).
All Doppler echocardiographic data were obtained in digital
format and stored on a workstation for off-line analysis
(EchoPAC, GE Vingmed Ultrasound AS, Horten, Norway). All
measurements were averaged over three cardiac cycles. MR was
quantiﬁed as previously described10 and recommended.15 The
RV and the ERO area were obtained. The LV diameters were
obtained from the parasternal long-axis view by 2D guided
M-mode using the leading edge methodology at end-diastole
and end-systole. The LV end-systolic and end-diastolic volumes
as well as the LVEF were obtained using the modiﬁed biplane
Simpson’s method. The LV forward stroke volume was calcu-
lated by multiplying the LV outﬂow tract area by the LV outﬂow
tract velocity–time integral measured by pulsed-wave Doppler.
Mitral E-wave and A-wave velocities were measured with
pulsed-wave Doppler, and e’-wave velocity was obtained using
tissue Doppler imaging at the septal position of the mitral
annulus. SPAP was derived from the regurgitant jet of tricuspid
regurgitation using systolic transtricuspid pressure gradient cal-
culated by the modiﬁed Bernoulli equation and the addition of
10 mm Hg for right atrial pressure as previously performed16
and validated.10 14 The right atrial pressure was assumed to be
constant from rest to exercise. Resting and exercise PHT were
deﬁned as a SPAP >50 and SPAP >60 mm Hg, respectively, as
recommended by current guidelines.3 4
Postoperative cardiac event-free survival
The last follow-up information was obtained from interviews
with the patients or physicians. Cardiac event was deﬁned as the
occurrence of postoperative cardiovascular-related death or
cardiovascular-related hospitalisation, stroke or atrial ﬁbrillation
(AF). A composite end point of major postoperative cardiovas-
cular event was deﬁned as the occurrence of cardiovascular-
related death or cardiovascular-related hospitalisation or stroke
(ie, exclusion of AF). The occurrence of postoperative AF was
separated into two phases: early AF (ie, within 48 h following
surgery) and late postoperative AF (>48 h). The follow-up
collection was complete in the 102 patients (100%).
Statistical analysis
Results are expressed as mean±SD, median (25–75% interquar-
tile) or number (percentage) unless otherwise speciﬁed. Before
analysis, normality distribution was tested with the
Kolmogorov-Smirnov test. Differences between groups (ie, accord-
ing to the presence or absence of exercise PHT) were analysed for
statistical signiﬁcance with the Student t test, Mann-Whitney
U test, χ2 test or Fisher’s exact test, when appropriate. The linear
relationship between echocardiographic parameters was visually
assessed using scatterplot and the coefﬁcients of correlation
reported were obtained from Pearson’s or Spearman’s test, as
appropriate.
Probabilities of cardiac event-free survival were obtained by
Kaplan-Meier estimates and then compared by the use of a two-
sided log-rank test. Cox proportional hazards models were used
in univariable and multivariable analyses to identify the inde-
pendent predictors of cardiac event-free survival. Values of
p<0.05 were considered statistically signiﬁcant and all statistical
tests were two-sided. All statistical analyses were performed
with STATISTICAV.7 (StatSoft, Tulsa, Oklahoma, USA).
RESULTS
Among the 102 patients, 59 (58%) developed exercise PHT.
Patients with exercise PHT were signiﬁcantly older and had
higher prevalence of systemic hypertension (table 1). There was
no other statistically signiﬁcant difference between the two
groups regarding demographic and clinical data, as well as
resting and exercise heart rates and blood pressure. The two
groups reached similar peak exercise workload (table 1). The







(n=59, 58%) p Value
Age, years 64±12 61±13 67±11 0.01
Male, n (%) 69 (68) 29 (67) 41 (69) 0.76
Renal failure, n (%) 4 (4) 2 (5) 2 (3) 0.93
Systemic hypertension, n (%) 47 (46) 13 (32) 34 (57) 0.01
Diabetes, n (%) 7 (7) 2 (5) 5 (9) 0.40
Hypercholesterolaemia, n (%) 33 (32) 14 (33) 19 (32) 0.93
Resting heart rate, bpm 72±12 69±10 75±13 0.05
Resting systolic BP, mm Hg 138±20 140±20 136±20 0.43
Resting diastolic BP, mm Hg 78±10 77±11 78±10 0.78
Exercise workload, W 80±33 76±29 86±37 0.21
Exercise heart rate, bpm 122±17 121±18 124±15 0.46
Exercise systolic BP, mm Hg 174±32 173±36 174±28 0.92
Exercise diastolic BP, mm Hg 90 [75–90] 90 [75–90] 89 [76.5–92] 0.72
p values in bold are significant.
BP, blood pressure; ExPHT, exercise pulmonary hypertension.
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time interval between baseline exercise stress echocardiography
and surgery was 2 (0.5; 7) months, without signiﬁcant differ-
ence between the two groups (no exercise PHT: 2 (0.7; 9)
months, exercise PHT: 2 (0.2; 4) months, p=0.25). Fifty-ﬁve
(55; 55%) were operated on the basis of a Class I indication
and 45 (45%) on the basis of a Class IIa indication. Although
patients with moderate MR at the time of baseline exercise
stress echocardiography were included, all patients were oper-
ated with severe MR, according to guidelines recommendation.
Echocardiographic data
Baseline severe MR was observed in 83 (81%) patients (table 2).
The SPAP signiﬁcantly increased during exercise (from 37
±11 mm Hg to 63±18 mm Hg, p<0.0001) and the
exercise-induced changes in SPAP were correlated with the
exercise-induced changes in RV (r=0.41, p=0.001). There was
a trend for weak signiﬁcant correlation between the
exercise-induced changes in SPAP and the changes in ERO
(r=0.24, p=0.07). As compared with patients without exercise
PHT, those with exercise PHT had signiﬁcantly higher resting
left atrium surface (p=0.001), exercise-induced increase in RV
(p=0.03) and in ERO (p=0.02, table 2). There was no other
statistically signiﬁcant difference between the two groups for
resting and exercise echocardiography data.
Operative and postoperative outcome
Mitral valve repair was performed in 80 (78%) patients,
without difference in the prevalence of exercise PHT (no exer-
cise PHT: n=33, 77% vs exercise PHT: n=48, 81%, p=0.59).
Mitral valve repair was performed using Carpentier Edwards







(n=59, 58%) p Value
Resting data
LV end-systolic diameter, mm 34±6 33±6 35±6 0.30
LV end-diastolic diameter, mm 55±8 55±8 56±8 0.56
LVEF, % 71 [66; 76] 70 [65; 77] 71 [68; 75] 0.68
Regurgitant volume, mL 66 [53; 90] 67 [52; 96] 65 [54; 87] 0.89
ERO area, mm² 40 [35; 60] 40 [38; 65] 40 [30; 60] 0.29
Left atrium surface, cm² 35 [24; 76] 27 [20; 66] 46 [29; 92] 0.001
E/e0 ratio 14±5 12±4 15±6 0.10
Systolic PAP, mm Hg 36 [30; 42] 33 [26; 39] 40 [33; 47] 0.001
Severe MR, n (%) 83 (81) 35 (81) 48 (81) 0.98
Exercise data
LVEF, % 71±9 72±9 71±8 0.54
Regurgitant volume, mL 75 [58; 98] 72 [46; 99] 75 [64; 95] 0.31
ERO area, mm² 50 [40; 73] 50 [40; 72] 53 [40; 74] 0.67
Systolic PAP, mm Hg 63±18 47±8 75±14 <0.0001
Severe MR, n (%) 83 (81) 31 (71) 52 (88) 0.12
Exercise; induced changes
Changes in regurgitant volume, mL +2 [−9; +14] +1 [−9; +10] 5 [−8; +21] 0.03
Changes in ERO area, mm² +8 [0; +20] 0 [−2; +10] 10 [0; +25] 0.02
Changes in systolic PAP, mm Hg +25 [+14; +33] +15 [+8; +21] +32 [+28; +43] <0.0001
E/e’ indicates the ratio of the E-wave on the e’-wave.
p value in bold are significant.
ERO, effective regurgitant orifice; ExPHT, exercise pulmonary hypertension; MR, mitral regurgitation; PAP, pulmonary arterial pressure.
Table 3 Distribution of total postoperative cardiovascular events according to ExPHT
Event Whole cohort n=102 No ExPHT (n=43, 42%) ExPHT (n=59, 58%) p Value
All AF, n (%) 19 (19) 4 (9) 15 (25) 0.07
Early AF, n (%) 5 (5) 1 (2) 4 (7) 0.57
Hospitalisation, n (%) 12 (12) 1 (2) 11 (19) 0.027
Acute pulmonary oedema, n (%) 2 (2) 0 (0) 2 (3) NA
Stroke, n (%) 6 (6) 1 (2) 5 (8) 0.38
Death, n (%) 4 (4) 0 (0) 4 (7) NA
All events*, n (%) 28 (27) 5 (12) 23 (39) 0.005
Events without early AF*, n (%) 23 (23) 4 (9) 19 (32) 0.013
Major CV events*, n (%) 11 (11) 2 (5) 9 (15) 0.16
p value in bold are significant.
*Indicates that the number and rate reported show the occurrence of the first postoperative event.
AF, atrial fibrillation; CV, cardiovascular; ExPHT, exercise pulmonary hypertension.
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Physio ring (69%), Medtronic CG Future (29%) and Edwards
Cosgrove (2%), without difference between the two groups.
Fifty per cent of patients who undergo mitral valve replacement
received a biological prosthesis, without signiﬁcant difference
between patients with exercise PHT and those without exercise
PHT. Concomitant coronary artery bypass graft was performed
in nine patients (9%). There was no operative mortality.
During a mean postoperative follow-up of 50±23 months
(range: 10–128 months), 28 patients (27%) experienced a pre-
deﬁned cardiovascular event. All events are summarised in
table 3. The ﬁrst occurring events were 4 cardiovascular deaths
(14% of all events), 3 cardiac-related hospitalisations (11%),
4 strokes (14%), 5 early AFs (18%) and 14 late AFs (50%).
Among the four deaths, three occurred following hospitalisation
for worsening heart failure and one after fatal stroke. In these
four patients, three have undergone mitral valve repair and one,
mitral valve replacement. Patients with exercise PHT had a sig-
niﬁcantly higher rate of postoperative overall cardiovascular
event than those without exercise PHT (n=23, 39% vs n=5,
12%, p=0.005, table 3). After exclusion of early AF, exercise
PHT was also associated with increased rate of cardiovascular
events (n=19, 32% vs n=4, 9%, p=0.013, table 3). Among the
11 major cardiovascular events (ie, cardiac death or hospitalisa-
tion or stroke), 9 (75%) occurred in the group of patients with
exercise PHT (p=0.16).
The exclusion of patients with baseline resting PHT yielded
similar results: exercise PHT remained associated with higher
rate of overall postoperative cardiovascular event (35% vs 9%,
p=0.002) and of postoperative cardiovascular event without
early AF (26% vs 6%, p=0.01).
Postoperative event-free survival
The overall postoperative cardiac event-free survivals were 80
±4%, 79±4%, 79±4% and 71±6% at 1 year, 2 years, 3 years
and 5 years, respectively. There was no signiﬁcant difference in
postoperative 5-year cardiac event-free survival between mitral
valve repair and mitral valve replacement (p=0.50). Patients
with or without resting PHT had statistically similar post-
operative event-free survival (overall events: p=0.91; events
without early AF: p=0.48). On the other hand, patients with
exercise PHT had markedly lower event-free survival than those
without exercise PHT (1-year: 75±6 vs 88±5%, 3-year: 73±6
vs 88±5%, 5-year: 60±8%, vs 88±5%, p=0.007, ﬁgure 1).
The exclusion of early AF provided similar results with signiﬁ-
cantly lower event-free survival in the exercise PHT group
(1-year: 83±5 vs 90±4%, 3-year: 79±5 vs 90±4%, 5-year: 67
±7%, vs 90±4%, p=0.02, ﬁgure 2).
When patients with baseline resting PHTwere excluded, exer-
cise PHT remained signiﬁcantly associated with lower overall
event-free survival and event-free survival without early AF
(1-year: 78±6 vs 91±4%, 3-year: 74±6 vs 91±4%, 5-year: 60
±8%, vs 91±4%, p=0.004 and 1-year: 85±5 vs 93±4%,
3-year: 81±5 vs 93±4%, 5-year: 70±8%, vs 93±5%,
p=0.024, respectively).
Using Cox proportional hazards model, exercise PHT was
associated with a 1.9-fold increased risk of overall postoperative
events (p=0.0096) and 1.8-fold increased risk of postoperative
events without early AF (p=0.017, table 4). After adjustment
for age and sex, exercise PHT remained signiﬁcantly associated
with postoperative cardiovascular event (overall: p=0.0045,
without early AF: p=0.008). Further adjustment for the para-
meters used as class I indication for surgery in the most recent
ESC and ACC/AHA guidelines (ie, LV end-systolic diameter,
LVEF and baseline NYHA functional class) yielded to signiﬁcant
association between preoperative exercise PHT and post-
operative overall events (all p≤0.01) and events without early
AF (all p≤0.05), respectively (table 4).
Similarly, after adjustment for age, sex, LVEF and preoperative
NYHA functional class (ie, at the time of surgery), exercise PHT
remained associated with a signiﬁcantly higher risk of worse
outcome (table 4).
DISCUSSION
The present study conﬁrms that resting PHT is uncommon (9%)
in asymptomatic or mildly symptomatic patients with primary
MR, preserved LV function and no LV dilatation. In contrast,
exercise PHT is more frequent (58%) and represents a major
determinant of postoperative cardiac event-free survival. Even
after adjustment for parameters related to class I indication for
surgery of the most recent guidelines, exercise PHT remains
associated with a twofold increased risk of postoperative event.
Figure 2 Postoperative event-free survival without early atrial
ﬁbrillation (AF) according to the presence or absence of exercise
pulmonary hypertension (PHT). Percentages reported are the survival
rates at 1-, 3-, 5-, and 7-year of follow-up.
Figure 1 Postoperative overall event-free survival according to the
presence or absence of exercise pulmonary hypertension (PHT).
Percentages reported are the survival rates at 1-, 3-, 5-, and 7-year of
follow-up.
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Pathophysiology of exercise PHT
In contrast with resting PHT, which is mainly determined by
estimated LV ﬁling pressure and left atrial area, exercise PHT
more frequently occurs in patients with dynamic MR exhibiting
a marked exercise-induced increase in MR severity.10 11 During
exercise, the abrupt increase in MR severity, even if mild, may
exceed in some patients the level of left atrial compliance and
pulmonary vascular recruitment and leads to an increase in
SPAP up to PHT. Although initially benign with no signiﬁcant
consequences, such a phenomenon, when repetitive, can pro-
gressively conduct to left atrial dilatation, increased LV ﬁlling
pressure, AF, low-level exercise dyspnoea, and ﬁnally, resting
symptoms.17 In our study, the most common postoperative
event was AF, which is consistent with the larger left atrial
volume in patients exhibiting exercise PHT. The presence of a
dynamic MR could thus be the precursor of a cascade of
harmful pathophysiological abnormalities, starting with increase
in left atrial dimension and exercise PHT and leading to rapid
development of symptoms and higher risk of postoperative
cardiac events.
Postoperative outcome and exercise PHT
The most frequent postoperative outcome reported in this mul-
ticentre study was AF (including early and late occurrence). One
could argue that postoperative AF is not a ‘hard’ event and that
this result emphasises that exercise PHT is a benign condition.
However, AF in patients with primary MR is known to be asso-
ciated with worse outcome and increased morbidity and mortal-
ity when conservatively managed.18 The high rate of
postoperative AF, while likely related to left atrial enlargement
and older age, underlines that patients with exercise PHT are
probably at a more advanced stage of the disease. Hence, exer-
cise PHT, as assessed using exercise echocardiography, could be
a reasonable trigger for surgery in asymptomatic patients.
In patients with functional MR, changes in MR during exer-
cise were also associated with changes in SPAP19 and are
involved in the pathogenesis of acute pulmonary oedema.20
Although rare in primary MR, the two episodes of acute pul-
monary oedema observed in our series occurred in patients with
exercise PHT.
The four deaths in the whole cohort were in the group of
preoperative exercise PHT. The lack of statistical comparison
precludes meaningful conclusion regarding these data.
Nevertheless, from a clinical standpoint, these results strongly
suggest that preoperative exercise PHT is a powerful independ-
ent predictor of postoperative outcome (table 4).
As opposed to exercise PHT, resting PHT was not associated
with higher risk of cardiovascular events during follow-up. This
result is contrasting with current literature7 8 but is probably
related to the small number (n=9) of patients with resting PHT
in our study and important differences in inclusion criteria.
Clinical implication
Our group reported in 2010 that patients with exercise PHT are
more likely to rapidly develop symptoms during follow-up. This
ﬁnding was further conﬁrmed by larger series.9 The present
data now reveals that preoperative exercise PHT predicts a
2-fold increase in the risk of postoperative cardiovascular event,
regardless of the symptomatic status. Of note, the vast majority
of our patients were conservatively managed up to the ﬁrst
occurrence of class I or class IIa indications for surgery.
Consequently, our results suggest that this strategy recom-
mended by the guidelines may not be suitable for all patients,
and particularly in those with exercise PHT is not adequate and
could be improved. Indeed, early elective surgery in a high-
volume centre with high heart valve surgery experience seems
more appropriate in these patients since, when operated for
other indications than exercise PHT, their postoperative
outcome is signiﬁcantly worse. Early surgery appears safe and
associated with high postoperative survival in primary MR.21
Nonetheless, it does not seem reasonable to generalise an ‘early
surgery’ strategy to all asymptomatic patients. Indeed, operative
mortality rate is not null and the risk to perform mitral valve
replacement instead of valve repair exists.1 In contrast, conserva-
tive management could be proposed to patients without exercise
PHT, and a follow-up in a heart valve clinic could be recom-
mended.22 Furthermore, this strategy could also be improved by
the use of resting and exercise brain natriuretic peptide23 24 and
the assessment of LV longitudinal function24 and contractile
reserve.25
In our cohort, 11 patients (58%) with moderate MR devel-
oped exercise PHT. In accordance with current ESC and ACC/
AHA guidelines which do not recommend surgery in patients
with moderate MR, except when other cardiac surgery is indi-
cated (Class IIa, evidence C), we believe that patients with mod-
erate MR and exercise PHT should be followed very closely and
should undergo surgery as soon as they develop severe MR.
Limitations
The present series is relatively small and the number of post-
operative events is limited. This could lead to type II error.
However, the fact that exercise PHTwas signiﬁcantly associated
with reduced postoperative event-free survival suggests that this
relationship is strong. Furthermore, this is one of the largest
studies with this design and including such patients.
The surgical procedure was not standardised in this multicen-
tre study and depended on the surgeon preference. In this
Table 4 Impact of exercise pulmonary hypertension on cardiac event- free survival: Cox proportional hazards regression analysis
Analysis
All CV events CV events without early AF
HR 95% CI p Value HR 95% CI p Value
Univariable 1.9 1.1 to 3.4 0.0096 1.8 1.1 to 3.3 0.017
Age and sex adjusted 2.2 1.2 to 4.5 0.0045 2.1 1.2 to 4.5 0.008
Age, sex and LV end systolic diameter adjusted 2.2 1.2 to 4.5 0.0043 2.1 1.2 to 4.3 0.008
Age, sex and LVEF* adjusted 2.2 1.3 to 4.8 0.0031 2.0 1.1 to 4.3 0.013
Age, sex, LVEF and baseline NYHA class adjusted 2.0 1.2 to 4.3 0.01 1.8 1.0 to 3.7 0.04
Age, sex, LVEF and preoperative NYHA class adjusted 2.0 1.2 to 1.8 0.0041 2.0 1.2 to 4.3 0.0087
AF, atrial fibrillation; CV, cardiovascular; NYHA, New York Heart Association.
*LVEF was incorporated without LV end systolic diameter in order to avoid collinearity.
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regard, some uncontrolled confounding surgical factors may
have impacted the postoperative course. Nevertheless, this could
not inﬂuence the main ﬁndings of this study.
Due to the small number of patients with resting PHT in this
study (n=9), we did not perform any comparison of this subset
versus patients with no resting PHT and no exercise PHT and
versus patients with no resting PHTand exercise PHT.
CONCLUSION
In patients with primary MR, no or mild symptoms, and no LV
dysfunction/dilatation, the development of exercise PHT is a
major risk factor for cardiovascular events following subsequent
mitral valve surgery, regardless of symptom onset during the
preoperative course. The results of this study suggest that
asymptomatic patients with exercise PHT may beneﬁt from
early elective surgical intervention as suggested by current
guidelines, or should, at least, be referred to heart valve clinic
and be closely follow-up. Furthermore, these data emphasise the
usefulness of exercise stress echocardiography in asymptomatic
patients with primary MR.
Key messages
What is known on this subject?
Patients with chronic primary mitral regurgitation and who develop
exercise pulmonary hypertension are at higher risk of frequent and
rapid development of symptoms during the follow-up.
What might this study add?
This study shows that exercise pulmonary hypertension in chronic
primary mitral regurgitation is associated with reduced
postoperative cardiac event-free survival and multiplies by 2 the
risk of postoperative event, even after adjustment for parameters
considered as trigger for surgery in current guidelines.
How might this impact on clinical practice?
These data emphasise the usefulness of exercise stress
echocardiography in patients with primary mitral regurgitation.
It also demonstrates that exercise stress echocardiography and
the assessment of exercise pulmonary hypertension may identify
a group of patients at high risk of postoperative cardiac event.
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